Blogs- iCareAb Biotechnology co.ltd

Blogs

Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate

VelaVigo Secures Exclusive Licensing Option for Nectin4/TROP2 Bispecific Antibody-Drug Conjugate with Avenzo

Nanobody: the hope for future medicine

Nanobody Breakthrough: Targeting Liver Inflammation with Pannexin-Specific Precision

2025 © iCareAb Biotechnology co.ltd All Rights Reserved.

Designed by wzcoder.com